Supplemental oxygen users with pulmonary fibrosis perceive greater dyspnea than oxygen non-users

Multidisciplinary Respiratory Medicine

Volumn 10, Issue 1, 2015, Pages

  Cao, Mengshu ^a   Wamboldt, Frederick S ^b   Brown, Kevin K ^b   Hickman, Jonathon ^c   Olson, Amy L ^b   Solomon, Joshua J ^b   Swigris, Jeffrey J ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b DEPARTMENT OF MEDICINE   (United States)

^c Exempla Saint Joseph Hospital   (United States)

Author keywords

6 min walk test; Dyspnea; Interstitial lung disease; Pulmonary fibrosis; Supplemental oxygen

Indexed keywords

AGED; ARTERIAL OXYGEN SATURATION; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED VITAL CAPACITY; FUNCTIONAL ASSESSMENT; HEART RATE; HUMAN; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; OXYGEN DESATURATION; OXYGEN THERAPY; PREDICTION; SIX MINUTE WALK TEST;

EID: 84951837211     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/s40248-015-0035-y     Document Type: Article

References (15)

1. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999;159(1):321-40
2. Laveneziana P. Qualitative aspects of exertional dyspnea in patients with restrictive lung disease. Multidiscip Resp Med. 2010;5(3):211-5.
3. O'Donnell DE, Chau LK, Webb KA. Qualitative aspects of exertional dyspnea in patients with interstitial lung disease. J Appl Physiol. 1998;84(6):2000-9.
4. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Ogawa T, et al. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD. Respir Med. 2007;101(4):833-8.
5. Frank RC, Hicks S, Duck AM, Spencer L, Leonard CT, Barnett E. Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit? Eur Respir J. 2012;40(1):269-70.
6. Visca D, Montgomery A, de Lauretis A, Sestini P, Soteriou H, Maher TM, et al. Ambulatory oxygen in interstitial lung disease. Eur Respir J. 2011;38(4):987-90.
7. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000;161(2 Pt 1):646-64.
8. Joint Statement of the American Thoracic Society and European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277-304.
9. Raghu G, Collard H, Egan J, Martinez F, Behr J, Brown K, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824.
10. Travis WD, Costabel U, Hansell DM, King Jr TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733-48.
11. ATS statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-7.
12. Borg G. Borg's perceived exertion and pain scales. Champaign: Human Kinetics; 1998.
13. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD. 2005;2(1):105-10.
14. Mahler DA, O'Donnell DE. Recent advances in dyspnea. Chest. 2015;147(1):232-41.
15. Faisal A, Alghamdi BJ, Ciavaglia CE, Elbehairy AF, Webb KA, Ora J, et al. Common Mechanisms of Dyspnea in Chronic Interstitial and Obstructive Lung Disorders. Am J Respir Crit Care Med. 2015, 10.1164/rccm.201504-0841OC.